Role of nuclear receptor corepressors in leukemogenesis

Current Topics in Microbiology and Immunology

Volumn 254, Issue , 2000, Pages 165-185

  Guidez, F ^a   Zelent, A ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; HYBRID PROTEIN; RECEPTOR PROTEIN; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR;

GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HEMATOPOIESIS; LEUKEMIA; LEUKEMOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL NUCLEUS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; GENE REARRANGEMENT; HEMATOPOIESIS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 0033635721     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (146)

1. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
2. Retinoids and cells of the hematopoietic system
3. Histone acetylation and cancer
4. Groucho-dependent and -independent repression activities of Runt domain proteins
5. The CBP co-activator is a histone acetyltransferase
6. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors msugl and Tifl
7. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation
8. Oncogenes as hormone receptors
9. A PML-RARα transgene initiates murine acute promyelocytic leukemia
10. Molecular biology of acute myeloid leukemia
11. A decade of molecular biology of retinoic acid receptors
12. Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents
13. A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development
14. A transcriptional co-repressor that interacts with nuclear hormone receptors
15. Two distinct actions of retinoid-receptor ligands
16. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-α locus due to a variant t(11;17) translocation associated with acute promeylocytic leukaemia
17. PLZF-RARα fusion proteins generated from the variant t(11;17)(q23;21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors
18. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha
19. Expression of the zine-finger gene PLZF at rhombomere boundaries in the vertebrate hindbrain
20. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist
21. Histone deacetylase associated with mSin3A mediates repression by the promyelocytic leukemia-associated PLZF protein
22. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
23. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptorgamma ligand troglitazone in patients with liposarcoma
24. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein
25. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy
26. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyclocytic leukemia zinc finger-retinoic acid reccptor-α fusion protein
27. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling
28. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
29. Transgenic expression of PML-RARalpha impairs myelopoiesis
30. Characterization of a human RPD3 ortholog, HDAC3
31. Transcription factors in hematopoiesis
32. Loops, lineage, and leukemia
33. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt
34. Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter
35. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein
36. Groucho proteins: Transcriptional corepressors for specific subsets of DNA-binding transcription factors in vertebrates and invertebrates
37. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family
38. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid lcukemia fusion partner ETO
39. The coregulator exchange in transcriptional functions of nuclear receptors
40. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia
41. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
42. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia
43. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response
44. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia
45. Three proteins define a class of human histone deacetylases related to yeast Hdalp
46. Histone acetylation in chromatin structure and transcription
47. Reduced retinoic acid-sensitivities of nuclear receptor co-repressor binding to PML- and PLZF-RARα underlic molecular pathogenesis and treatment of acute promyelocytic leukemia
48. Childhood leukemia associated TEL-AML1 oncoprotein binds nuclear receptor co-repressor N-CoR and functions as a histone deacetylase dependent transcriptional repressor
49. Histone deacetylase activity is required for full transcriptional repression by mSin3A
50. Nuclear histone acetylases and deacetylases and transcriptional regulation
51. Distinct interactions of PML-RARα with transcriptional co-repressors determine differential responses to retinoic acid in APL
52. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice
53. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
54. Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors
55. Transcriptional regulation by the t(8;21) fusion protein, AML-1/ETO
56. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription
57. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF
58. Hematopoietic studies in vitamin A deficiency
59. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated With acute promyelocytic leukemia
60. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
61. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300
62. Eukaryotic transcription: An interlaced network of transcription factors and chromatin-modifying machines
63. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARe with a novel putative transcription factor, PML
64. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
65. Retinoic acid nuclear receptors
66. Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins
67. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas
68. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetyhtse
69. Repression and activation by multiprotein complexes that alter chromatin structure
70. Interaction and functional cooperation of the leukemia-associated factors AMLI and p300 in myeloid cell differentiation
71. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient
72. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion
73. Leukemia associated retinoic acid receptor α fusion partners, PML and PLZF, hetcrodimerize and colocalize to nuclear bodies
74. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression
75. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
76. A positive role for histone acetylation in transcription factor access to nucleosomal DNA
77. Multiplicity generates diversity in the retinoic acid signalling pathways
78. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently
79. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors
80. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)
81. Role of histone deacetylase complex in acute promyelocytic leukaemia
82. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia
83. Oncogenic transcription factors in the human acute leukemias
84. The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor
85. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia
86. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors
87. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid
88. The RXR heterodimers and orphan receptors
89. Involvement of retinoic acid receptor-α-mediated signaling pathway in induction of CD38 cell-surface antigen
90. Identification of AML-1 and (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: The runt homology domain is required for DNA binding and protein-protein interactions
91. HDAC4 deacetylase associates with and represses the MEF2 transcription factor
92. Generation of the AML1-EVI-1 fusion gene in t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia
93. t(8;21) breakpoints in chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1
94. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
95. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha
96. AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene
97. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
98. Sequence and characterization of a coactivator for the steroid-hormone receptor superfamily
99. Development of the hematopoietic system
100. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias
101. Structure and origin of the acute promyelocytic leukemia myl/RARα cDNA and characterization of its retinoid-binding and transactivation properties
102. PMLRAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR
103. PML induces a novel caspase-independent death process
104. The t(5;17) APL fusion protein NPM-RAR does not alter PML localization
105. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion
106. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors
107. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
108. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation
109. Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity
110. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
111. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro
112. CBFA2 (AML1) translocations with novel partner chromosomes in myeloid leukemias: Association with prior therapy
113. The critical role of chromosome translocations in human leukemias
114. The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis
115. The transcriptional control of hematopoiesis
116. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
117. Steroid receptor coactivator-1 is a histone acetyltransferase
118. The unique aspects of acute promyelocytic leukaemia
119. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promote activity by AML1-related transcription factor, PEBP2
120. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias
121. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p
122. Transcription factors, normal myeloid development, and leukemia
123. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage
124. AML1A and AML1B can transactivate the human IL-3 promoter
125. Role of the histone amino termini in facilitated binding of a transcription factor, GAL4-AH, to nucleosome cores
126. Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences
127. TIF2, a 160kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
128. HDAC4, a human histone deacetyhtse related to yeast HDA1, is a transcriptional corepressor
129. Transcriptional mprcssion in Saccharomyces cerevisiae by a SIN3-LexA fusion protein
130. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex
131. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells
132. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo
133. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor
134. Role of PML in cell growth and the retinoic acid pathway
135. Rctinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies and implications
136. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
137. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells
138. Fusion of retinoic acid receptor α to NuMA, the mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia
139. Tissue changes following deprivation of fat-soluble A vitamin
140. Transcriptional repression by the SMRT-mSin3 corepressor: Multiple interactions, multiple mechanisms, and a potential role for TFIIB
141. Alterations of u zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma
142. Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function
143. Cloning of murine α and β retinoic acid receptors and a novel receptor γ predominantly expressed in skin
144. Differential expression of retinoid receptors during multilineage differentiation of haemopoietic progenitor cells-role of the RARα2 isoform in normal granulopoiesis and leukaemia
145. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA
146. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins